249.20
price down icon1.75%   -4.45
 
loading
Schlusskurs vom Vortag:
$253.65
Offen:
$251.56
24-Stunden-Volumen:
297.76K
Relative Volume:
0.65
Marktkapitalisierung:
$9.72B
Einnahmen:
$1.24B
Nettoeinkommen (Verlust:
$42.23M
KGV:
235.09
EPS:
1.06
Netto-Cashflow:
$150.33M
1W Leistung:
-3.32%
1M Leistung:
-5.67%
6M Leistung:
-12.07%
1J Leistung:
+33.34%
1-Tages-Spanne:
Value
$245.78
$253.00
1-Wochen-Bereich:
Value
$245.78
$259.83
52-Wochen-Spanne:
Value
$186.09
$310.00

Penumbra Inc Stock (PEN) Company Profile

Name
Firmenname
Penumbra Inc
Name
Telefon
(510) 995-2486
Name
Adresse
ONE PENUMBRA PLACE, ALAMEDA, CA
Name
Mitarbeiter
4,500
Name
Twitter
@penumbrainc
Name
Nächster Verdiensttermin
2025-02-18
Name
Neueste SEC-Einreichungen
Name
PEN's Discussions on Twitter

Vergleichen Sie PEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
PEN
Penumbra Inc
249.20 9.89B 1.24B 42.23M 150.33M 1.06
Medical Devices icon
ABT
Abbott Laboratories
133.31 233.03B 43.11B 13.94B 6.78B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
98.14 145.30B 18.49B 2.50B 3.49B 1.68
Medical Devices icon
SYK
Stryker Corp
368.57 141.92B 23.82B 2.92B 4.02B 7.55
Medical Devices icon
MDT
Medtronic Plc
94.30 122.80B 34.20B 4.69B 5.30B 3.63
Medical Devices icon
EW
Edwards Lifesciences Corp
75.27 43.83B 5.69B 1.41B 577.90M 6.95

Penumbra Inc Stock (PEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-02 Eingeleitet Evercore ISI Outperform
2025-03-14 Eingeleitet BofA Securities Buy
2025-01-21 Eingeleitet UBS Buy
2024-12-17 Eingeleitet Oppenheimer Outperform
2024-12-11 Hochstufung Wells Fargo Equal Weight → Overweight
2024-09-18 Eingeleitet Stifel Buy
2024-09-03 Eingeleitet Leerink Partners Outperform
2024-07-31 Herabstufung Citigroup Buy → Neutral
2024-07-31 Herabstufung Wells Fargo Overweight → Equal Weight
2024-02-23 Herabstufung JP Morgan Overweight → Neutral
2023-09-06 Eingeleitet Morgan Stanley Equal-Weight
2023-07-19 Eingeleitet Robert W. Baird Outperform
2023-03-29 Herabstufung Needham Buy → Hold
2023-01-30 Eingeleitet Piper Sandler Overweight
2022-11-04 Hochstufung Citigroup Neutral → Buy
2022-10-12 Eingeleitet Jefferies Buy
2022-10-05 Herabstufung Citigroup Buy → Neutral
2022-09-09 Hochstufung Needham Hold → Buy
2022-07-18 Eingeleitet RBC Capital Mkts Outperform
2022-04-19 Eingeleitet Deutsche Bank Buy
2022-03-08 Eingeleitet Needham Hold
2021-09-16 Eingeleitet Truist Buy
2021-06-04 Hochstufung BTIG Research Neutral → Buy
2020-12-16 Herabstufung BTIG Research Buy → Neutral
2020-10-07 Fortgesetzt Canaccord Genuity Buy
2020-09-29 Eingeleitet BTIG Research Buy
2020-09-08 Herabstufung BofA Securities Buy → Neutral
2020-03-05 Eingeleitet Citigroup Buy
2019-06-13 Bestätigt BofA/Merrill Buy
2019-05-30 Hochstufung JP Morgan Neutral → Overweight
2019-05-21 Eingeleitet William Blair Outperform
2018-10-29 Fortgesetzt BofA/Merrill Buy
2018-10-08 Eingeleitet RBC Capital Mkts Outperform
2018-02-21 Eingeleitet William Blair Outperform
2018-01-02 Herabstufung JP Morgan Overweight → Neutral
2015-11-30 Bestätigt Canaccord Genuity Buy
2015-10-13 Eingeleitet Wells Fargo Outperform
Alle ansehen

Penumbra Inc Aktie (PEN) Neueste Nachrichten

pulisher
Sep 25, 2025

Merit Medical Systems, ICU Medical, and Penumbra Stocks Trade Down, What You Need To Know - FinancialContent

Sep 25, 2025
pulisher
Sep 22, 2025

Diversified Trust Co Grows Stock Position in Penumbra, Inc. $PEN - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Penumbra’s SWOT analysis: thrombectomy leader’s stock poised for growth By Investing.com - Investing.com South Africa

Sep 22, 2025
pulisher
Sep 22, 2025

Penumbra’s SWOT analysis: thrombectomy leader’s stock poised for growth - Investing.com

Sep 22, 2025
pulisher
Sep 22, 2025

What moving averages say about Penumbra Inc.July 2025 Earnings & Technical Buy Zone Confirmations - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Cuts Position in Penumbra, Inc. $PEN - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Risks Report: Is Foxx Development Holdings Inc. stock suitable for long term investingJuly 2025 EndofMonth & Smart Investment Allocation Tips - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Trend Recap: Is Penumbra Inc showing insider buyingJuly 2025 Levels & Low Risk Investment Opportunities - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Voya Investment Management LLC Has $25.32 Million Stake in Penumbra, Inc. $PEN - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Penumbra, Inc. $PEN Shares Purchased by E. Ohman J or Asset Management AB - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

Risk On: What analysts say about Penumbra Inc stock2025 Volatility Report & Fast Gaining Stock Reports - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Sentiment Review: Is IRIDEX Corporation exposed to currency risksWeekly Stock Summary & Risk Adjusted Buy/Sell Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Intraday pattern recognizer results for Penumbra Inc.Gap Up & Scalable Portfolio Growth Ideas - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Forecasting Penumbra Inc. price range with options data2025 Fundamental Recap & Capital Protection Trading Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

What institutional flow reveals about Penumbra Inc.Market Growth Summary & Stock Portfolio Risk Management - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Belpointe Asset Management LLC Makes New Investment in Penumbra, Inc. $PEN - MarketBeat

Sep 19, 2025
pulisher
Sep 18, 2025

What Makes Penumbra (PEN) a Good Investment? - Yahoo

Sep 18, 2025
pulisher
Sep 18, 2025

Sheets Smith Investment Management Makes New $773,000 Investment in Penumbra, Inc. $PEN - MarketBeat

Sep 18, 2025
pulisher
Sep 17, 2025

Sentiment Review: Is Penumbra Inc. stock good for income investorsInflation Watch & Weekly Watchlist for Hot Stocks - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Fortis Capital Advisors LLC Acquires New Holdings in Penumbra, Inc. $PEN - MarketBeat

Sep 17, 2025

Finanzdaten der Penumbra Inc-Aktie (PEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$323.58
price down icon 1.04%
medical_devices STE
$244.19
price down icon 0.73%
medical_devices PHG
$26.56
price down icon 3.07%
$68.30
price up icon 1.19%
$71.50
price down icon 3.35%
medical_devices EW
$75.27
price up icon 0.82%
Kapitalisierung:     |  Volumen (24h):